FDA TO EASE PART 11 ENFORCEMENT IN CLINICAL TRIALS

Drug Industry Daily
KEYWORDS FDA / Guidances / Trial
A A

The FDA will not, for the most part, enforce 21 CFR Part 11 rules related to computerized systems used in clinical trials, according to a draft guidance issued Sept. 29.

To View This Article:

Login

Subscribe To Drug Industry Daily